(Q40749519)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8176017%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

review article

1 reference

title

Severe adverse cardiovascular effects of pulse steroid therapy: is continuous cardiac monitoring necessary? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8176017%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

author name string

K P White

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8176017%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

M S Driscoll

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8176017%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

M J Rothe

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8176017%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

J M Grant-Kels

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8176017%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

language of work or name

English

0 references

publication date

1 May 1994

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8176017%20AND%20SRC:MED&resulttype=core&format=json

Journal of the American Academy of Dermatology

26 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8176017%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

volume

30

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8176017%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

issue

5 Pt 1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8176017%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

page(s)

768-773

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8176017%20AND%20SRC:MED&resulttype=core&format=json

Initial treatment of renal allografts with large intrarenal doses of immunosuppressive drugs

26 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2808%2981508-3

7 January 2021

Reversal of acute clinical and experimental organ rejection using large doses of intravenous prednisolone

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2808%2981508-3

7 January 2021

Pyoderma gangrenosum associated with systemic lupus erythematosus: response to pulse steroid therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2808%2981508-3

7 January 2021

Successful treatment of aggressive pyoderma gangrenosum with pulse steroids and chlorambucil

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2808%2981508-3

7 January 2021

Intermittent high-dose dexamethasone-cyclophosphamide therapy for pemphigus

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2808%2981508-3

7 January 2021

Dexamethasone-cyclophosphamide pulse therapy in pemphigus

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2808%2981508-3

7 January 2021

D-penicillamine induced pemphigus treated with methylprednisolone pulse therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2808%2981508-3

7 January 2021

High-dose methylprednisolone in the treatment of bullous pemphigoid

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2808%2981508-3

7 January 2021

Epidermolysis bullosa acquisita in identical twins

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2808%2981508-3

7 January 2021

Pulse methylprednisolone therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2808%2981508-3

7 January 2021

Phenytoin hypersensitivity reaction presenting with toxic epidermal necrolysis and severe hepatitis. Report of a patient treated with corticosteroid "pulse therapy"

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2808%2981508-3

7 January 2021

Erythema multiforme major in a 2-month-old child with human immunodeficiency virus (HIV) infection

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2808%2981508-3

7 January 2021

Intermittent megadose corticosteroid therapy for generalized lichen planus

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2808%2981508-3

7 January 2021

Pulse methylprednisolone therapy for persistent subacute cutaneous lupus

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2808%2981508-3

7 January 2021

Multicentric reticulohistiocytosis: response to dexamethasone pulse therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2808%2981508-3

7 January 2021

Intravenous corticosteroids for systemic mastocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2808%2981508-3

7 January 2021

Double blind placebo controlled trial of pulse treatment with methylprednisolone combined with disease modifying drugs in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2808%2981508-3

7 January 2021

Intravenous pulse methylprednisolone therapy in severe inflammatory eye disease

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2808%2981508-3

7 January 2021

Treatment of steroid-resistant focal segmental glomerulosclerosis with pulse methylprednisolone and alkylating agents

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2808%2981508-3

7 January 2021

A study of adverse effects of high-dose intravenous (pulse) methylprednisolone therapy in patients with rheumatic disease

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2808%2981508-3

7 January 2021

Pulse steroid therapy in rheumatoid arthritis: can equivalent doses of oral prednisolone give similar clinical results to intravenous methylprednisolone?

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2808%2981508-3

7 January 2021

Sudden Appearance of Cardiac Arrhythmias After Dexamethasone

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2808%2981508-3

7 January 2021

Sudden death after methylprednisolone pulse therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2808%2981508-3

7 January 2021

Fatal Arrhythmia After Pulse Methylprednisolone Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2808%2981508-3

7 January 2021

Successful renal transplantation in a patient with anaphylactic reaction to Solu-Medrol (methylprednisolone sodium succinate)

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2808%2981508-3

7 January 2021

Anaphylactoid reaction to methylprednisolone pulsed therapy for multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2808%2981508-3

7 January 2021

Effects of high-dose intravenous methylprednisolone on circulation in humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2808%2981508-3

7 January 2021

Arrhythmia after pulse methylprednisolone therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2808%2981508-3

7 January 2021

Sudden death after treatment with pulsed methylprednisolone

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2808%2981508-3

7 January 2021

Atrial fibrillation following methylprednisolone pulse therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2808%2981508-3

7 January 2021

Combined suppressive drug treatment in severe refractory rheumatoid disease: an analysis of the relative effects of parenteral methylprednisolone, cyclophosphamide, and sodium aurothiomalate

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2808%2981508-3

7 January 2021

Pulse methylprednisolone therapy in severe idiopathic childhood nephrotic syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2808%2981508-3

7 January 2021

Holter Electrocardiogram Monitoring in Nephrotic Patients during Methylprednisolone Pulse Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2808%2981508-3

7 January 2021

Bradycardia after high-dose intravenous methylprednisolone therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2808%2981508-3

7 January 2021

Effects of a single large intravenous dose of methylprednisolone sodium succinate

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2808%2981508-3

7 January 2021

Holter monitoring in ankylosing spondylitis patients during methylprednisolone pulse therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2808%2981508-3

7 January 2021

Lupus nephritis: efficacy of monthly pulse therapy with intravenous methylprednisolone

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2808%2981508-3

7 January 2021

High-dose intravenous methylprednisolone pulse therapy in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2808%2981508-3

7 January 2021

Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2808%2981508-3

7 January 2021

Pulse methylprednisolone in rheumatoid arthritis: a double-blind cross-over trial

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2808%2981508-3

7 January 2021

Combination therapy with pulsed methylprednisolone in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2808%2981508-3

7 January 2021

Combination of methylprednisolone pulse therapy and remission inducing drugs in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2808%2981508-3

7 January 2021

Pulsed methylprednisolone in active early rheumatoid disease: a dose-ranging study

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2808%2981508-3

7 January 2021

High-dose intravenous methylprednisolone in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2808%2981508-3

7 January 2021

Acute changes in calcium and bone metabolism during methylprednisolone pulse therapy in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2808%2981508-3

7 January 2021

Catabolic effects of high-dose corticosteroids persist despite therapeutic benefit in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2808%2981508-3

7 January 2021

High dose intravenous methyl prednisolone (pulse therapy) in the treatment of rheumatoid disease

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2808%2981508-3

7 January 2021

High dose oral methylprednisolone in patients with rheumatoid arthritis: pharmacokinetics and clinical response

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2808%2981508-3

7 January 2021

Pulse methylprednisolone therapy in rheumatoid arthritis: unproved therapy, unjustified therapy, or effective adjunctive treatment?

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2808%2981508-3

7 January 2021

10.1016/S0190-9622(08)81508-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8176017%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

1 reference